Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fusion protein of tumour new-born blood vessel-specific bonding polypeptide and recombinant human Tum-5, and its preparation method

A technology of tumor neovascularization and fusion protein, which is applied in the field of tumor neovascularization-specific binding polypeptide and recombinant human Tum-5 fusion protein and its preparation, which can solve the problem of no anti-tumor effect

Inactive Publication Date: 2006-07-12
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The antigenic epitope of Tumstatin is located at the N-terminal 1-40 amino acids, and this sequence has no anti-tumor effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fusion protein of tumour new-born blood vessel-specific bonding polypeptide and recombinant human Tum-5, and its preparation method
  • Fusion protein of tumour new-born blood vessel-specific bonding polypeptide and recombinant human Tum-5, and its preparation method
  • Fusion protein of tumour new-born blood vessel-specific bonding polypeptide and recombinant human Tum-5, and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0056] 1. Construction of Tum-5 and Tum-5-NGR His fusion gene prokaryotic expression vector

[0057] 1.1 Construction of prokaryotic expression vector of Tum-5His fusion gene

[0058] According to the human Tum-5 gene sequence published in GenBank, the codons encoding Tum-5 amino acids were replaced with codons commonly used in Escherichia coli (which is conducive to the high-efficiency expression of the target protein in Escherichia coli), and the codon was handed over to Shanghai Boya Biotechnology Co., Ltd. The company synthesized the whole gene, introduced the SphI restriction site upstream and the HindIII restriction site downstream, and cloned the target gene into the vector pMD-18T, named pMD-18T-Tum-5.

[0059] After pMD-18T-Tum-5 was double-digested with SphI and HindIII, small fragments were recovered; after plasmid pQE30 (product of Qiagen Company) was double-digested with SphI and BamH1, large fragments were recovered. The above two fragments were ligated with T4 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Cell numberaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for preparing for tumour formingblood vessel peculiarity binding polypeptide and the admixture protein of human-5. The tumour formingblood vessel peculiarity binding polypeptid-CNGRCVSGCAGRC can separately combine with the tumour formingblood vessel endothelium cell surface high effect expressed aminopeptidase N (CD13). It establishes tumour formingblood vessel peculiarity binding polypeptide and the admixture protein of human-5 and obtains the high effect express in bacillus coli. It also discloses a method for preparing for human Tum-5. The Tum-5 is formed by the 54-132 bits amino acid near the N end of the Tumstatin, which is the function structure area of the Tumstatin anti-vascularization.

Description

technical field [0001] The invention belongs to the field of medical biotechnology, including gene cloning, gene recombination, expression of exogenous gene in prokaryotic cells, purification of target protein, in vitro activity measurement and physicochemical analysis of tumor neovascularization-specific binding polypeptide and recombinant human Tum-5 fusion protein Character identification and other technologies relate to an anti-tumor drug and its preparation method, in particular to a tumor neovascularization-specific binding polypeptide capable of specifically binding to tumor tissue neovascularization endothelial cells and tumor cells and a recombinant human Tum-5 fusion protein (Tum -5-NGR) and its preparation method. Background technique [0002] The application of the targeting peptide NGR has been introduced in detail in the patent "Tumor Angiogenesis-Specific Binding Polypeptide and Human α-Interferon Fusion Protein and Preparation" (pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/09C12P21/02
Inventor 孟洁如马楠颜真张英起
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com